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Abstract 
In the late 1960’s all the wolves in Scandinavia went extinct in the wild due to extensive 
hunting. In 1983 two new wolves immigrated and founded, together with a third immigrant 
in 1991, the population that exists today. Due to the fact that the population originates 
from less than a handful of individuals, the genetic variation is small. Between the years 
1973 and 2011, 23 wolves of the wolves that have been sampled for blood and tissue were 
used in this study. A hereditary form of blindness without a known genetic etiology has 
been reported among captive wolves in Sweden. In an attempt to find the disease-causing 
gene, the study population of wolves were analyzed for presence of disease-causing muta-
tions in the following monogenic eye diseases; Gr_PRA1, Type-A PRA, Cord1, Prcd-PRA 
and PLL. The analysis of eye diseases was performed with either real time PCR (TaqMan) 
or capillary electrophoresis (ABIPrism 3100). To gain further understanding about the ge-
netic complexity and degree of genetic variation in the Scandinavian wolf population, the 
wolves were also sampled and sequenced for their genetic variation in the MHC class II 
loci (DLA-DRB1, DLA,DQA1 and DLA-DQB1). In the monogenic eye tests all wolves 
tested normal, but this does not exclude the possibility that individuals in the population 
carry another mutation causing blindness. In MHC class II, eight haplotypes were found 
including eight DRB1, six DQA1 and seven DQB1 alleles. Compared to a common dog 
breed the Scandinavian wolf population has about half the MHC variation. Because of the 
lack of genetic variation, license hunting should be abandoned in favor of careful testing of 
genetic variation, and depending on the result, cautious selection of what animals to eu-
thanize. 
Keywords: MHC class II, DLA, PRA, PLL, Canis lupus 
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Sammanfattning 
I slutet av sextiotalet utrotades alla vargar i Skandinavien på grund av omfattande jakt. 
1983 immigrerade två vargar till Sverige och grundlade tillsammans med ytterligare en 
immigrant år 1991 den vargpopulation som finns idag. Eftersom populationen etablerades 
av så få vargar är den genetiska variationen liten. Mellan åren 1973 till 2011 provtogs var-
gar för blod och vävnad varav 23 användes i denna studie . Vargar i fångenskap i Sverige 
lider av en ärftlig form av blindhet med okänd genetisk härkomst. I ett försök att finna den 
orsakande mutationen analyserades den provtagna populationen för sjukdomsorsakande 
mutationer i följande monogena ögonsjukdomar; Gr_PRA1, Typ-A PRA, Cord1, Prcd-
PRA och PLL. Analysen av ögonsjukdomarna genomfördes med antingen realtids-PCR 
eller kapillärelektrofores. För att få ytterligare kunskap om den genetiska variationen hos 
vargarna utfördes en sekvensering av MHC klass II loci (DLA-DRB1, DLA,DQA1 och 
DLA-DQB1). För alla genetiska tester för ögonsjukdomar var vargarna normala. Hos MHC 
klass II fanns åtta haplotyper med åtta DRB1, sex DQA1 och sju DQB1 alleler. Jämfört 
med en vanlig hundras har den Skandinaviska vargpopulationen ungefär hälften av MHC 
variationen. På grund av den begränsade genetiska variationen borde licensjakt överges till 
förmån för grundliga tester för genetisk variation. Beroende på resultat skall djur noggrant 
utväljas för avlivning, eftersom det föreligger betydande risker att licensjakt kan resultera i 
ytterligare minskad genetisk variation. 
Nyckelord: MHC klass II, DLA, PRA, PLL, Canis lupus 
 
 3 
Abbreviations 
 
Bp  Base pair 
Cord1  Cone rod dystrophy 1 caused by a mutation in RPGGRIP1 
ddH2O  Double distilled water 
DLA Dog leukocyte antigen,  
DNA  Deoxyribonucleic acid 
dNTP  Deoxyribonucleic triphosphate 
DQA1  DQ alpha 1 
DQB1  DQ beta 1 
DRB1  DR beta 1 
GrPRA Golden Retriever Progressive retinal atrophy  
LD  Linkage disequilibrium 
mtDNA Mitochondrial DNA 
PCR  Polymerase chain reaction 
PDC  Phosphoducin 
PLL Primary lens luxuation  
PRA  Progressive Retinal Atrophy 
Prcd  Progressive rod cone degeneration 
SNP  Single nucleotide polymorphism  
 4 
Contents 
1 Background   6
2 Litterature Review   8
2.1 Domestication of wolves   ................................................................................................ 8
2.2 Dogs and wolves as model species   ............................................................................... 9
2.3 Diseases and defects   .................................................................................................. 10
2.4 Progressive Retinal Atrophy   ........................................................................................ 10
2.4.1 Cord1  ................................................................................................................ 11
2.4.2 Prcd-PRA   ......................................................................................................... 11
2.4.3 Gr_PRA1   .......................................................................................................... 11
2.4.4 Type-A PRA   ..................................................................................................... 11
2.5 PLL   .............................................................................................................................. 12
2.6 MHC   ............................................................................................................................ 12
3 Material and methods   14
3.1 The studied dog population   ......................................................................................... 14
3.2 The studied wolf population   ......................................................................................... 14
3.2.1 DNA extraction   ................................................................................................. 15
3.2.2 PCR   .................................................................................................................. 15
3.3 Monogenic tests  ........................................................................................................... 15
3.3.1 Cord1  ................................................................................................................ 16
3.3.2 SLC4A3   ............................................................................................................ 16
3.4 TaqMan   ....................................................................................................................... 17
3.4.1 PLL   ................................................................................................................... 17
3.4.2 Type-A PRA   ..................................................................................................... 17
3.4.3 Prcd-PRA   ......................................................................................................... 18
3.5 DLA   .............................................................................................................................. 18
3.5.1 PCR amplification and sequencing   ................................................................... 18
3.5.2 Sequence analysis   ........................................................................................... 19
4 Results   20
4.1 Gel electrophoresis   ...................................................................................................... 20
4.2 Genotyping by sequencing of MHC class II   ................................................................. 21
4.3 Monogenic tests  ........................................................................................................... 33
4.3.1 Gr_PRA1   .......................................................................................................... 33
4.3.2 Cord1  ................................................................................................................ 34
4.4 TaqMan   ....................................................................................................................... 35
4.4.1 Type-A PRA   ..................................................................................................... 35
4.4.2 Prcd-PRA   ......................................................................................................... 37
4.4.3 PLL   ................................................................................................................... 38
5 Discussion   39
5.1 Monogenic tests  ........................................................................................................... 39
5.2 MHC polymorphism   ..................................................................................................... 40
 5 
6 Conclusion   43
References   44
Research articles   ................................................................................................................. 44
Books   .................................................................................................................................. 47
Unpublished literature   ...................................................... Fel! Bokmärket är inte definierat.
Reports   ................................................................................................................................ 47
Press releases   ..................................................................................................................... 47
7 Appendix   48
Acknowledgement   51
 6 
1 Background 
The population of wolves (Canis lupus) on the Scandinavian Peninsula has 
gone through an extreme bottleneck causing severe inbreeding. In the late 60’s all 
the wolves went extinct in the wild due to extensive hunting (Wabaken et al. 
2001). In 1983 a pair of wolves that immigrated from Finland/Russia founded the 
population that exists today (Liberg et al. 2005). Three males have immigrated and 
joined the breeding population in later years, one in 1991 and two in 2008. Breed-
ing in very small populations, such as the Scandinavian wolf population causes 
inbreeding which in turn reduces fitness (Keller & Waller, 2002). Inbreeding may 
thereby increase the risk of extinction of the population (Newman and Pilson, 
1997). Populations that have experienced severe inbreeding can be genetically im-
proved even by a single immigrant. The male that immigrated in 1991 alleviated 
the inbreeding depression temporarily, causing quite rapid expansion of the popu-
lation (Vila et al. 2003).  
The domesticated dog (Canis lupus familiaris) is a useful model species for 
studying human genetic diseases because many diseases manifests in similar ways 
in both species. Some examples of shared genetic diseases include diabetes, atopic 
dermatitis, autoimmune diseases, epilepsies, and cancers. The wolf is the ancestral 
species of all modern dog breeds and therefore, the dog may be considered a sub-
species to the wolf. Consequently, the wolf is also an important model species 
since it can be used as a reference out group (Ke et al. 2010). 
In captive wolves originating from the now in the wild extinct wolf popula-
tion of Scandinavia, a hereditary form of blindness has been reported (Laikre et al. 
2003). The genetic cause for blindness has not been studied, why it was thought 
important to investigate the wild Scandinavian wolves for the presence of known 
disease-causing mutations in a set of common canine genetic eye diseases. The 
blindness in the captive wolf manifests itself by cataracts, retinal dysplasia and 
abnormal blood vessels of the retina (Laikre et al. 2003). 
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Major histocompatibility complex (MHC) class II molecules play an important 
role in the immune system of animals. Many loci in the Mhc region are character-
ized by an extensive level of polymorphism and high amino acid diversity. In 
many species it has been shown that the observed homozygosity is lower than ex-
pected under neutrality. This is consistent with different forms of diversifying se-
lection (e.g. overdominance and frequency dependent selection) acting on the Mhc 
region (Hedrick 1999). For example, it has been suggested that individuals being 
heterozygous at the MHC class I and II loci would have a better protection against 
a wider range of pathogens since they will have a greater ability of presenting a 
larger repertoire of peptide antigens. This selection model is referred to as 
overdominant selection (heterozygous advantage) and was first proposed by 
Doherty and Zinkernagel in 1975. Frequency-dependent selection (minority ad-
vantage) is another type of diversifying selection that would also maintain an ex-
tensive level of polymorphism at MHC loci. In the frequency-dependent model, 
the maintenance of alleles in the population is driven by host-pathogen interac-
tions (Takahata and Nei, 1990). Because of the crucial importance for MHC class 
II molecules in defense against pathogens, the second objective of this study was 
to assess the genetic variation at MHC class II loci in Scandinavian wolves. In the 
dog as well as wolf, MHC genes are called dog leukocyte antigens (DLA). 
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2 Literature Review 
 
2.1 Domestication of wolves 
The wolf (Canis lupus) and the dog (Canis lupus familiaris) both belong to the 
Canidae family (which contains 35 species), under the genus Canis. There are six 
other species of Canids; two types of wolves (the red wolf, C. rufus and the Ethio-
pian or Abyssinian wolf, C. simensis), the coyote (the prairie wolf, C. latrans) and 
three sub-species of jackals (the golden jackal, C. aureus, the black-backed jackal 
C. mesomelus and the side-striped jackal, C. adustus) (Swintonski et al. 1996). 
There is yet another sub-species of wolf, the Mexican wolf (C. baileyi), that be-
came extinct in the wild in the 1980’s but was reintroduced to its natural habitat in 
the 90’s. This wolf sub-species is the most endangered of all wolves and the popu-
lation today originates from only seven individuals (Fredrickson et al. 2007).  
Genetically, wolves and dogs are highly similar and have the same number of 
chromosomes, i.e. 78 chromosomes: 38 pairs of autosomes and two sex chromo-
somes (Swintonski et al. 1996). Phylogenetic analyses of mitochondrial DNA 
(mtDNA) indicate that purebred dogs were domesticated from their wild ancestor, 
the grey wolf (C. lupus), some 15000 years ago in southern China (Vilá et al. 
1997; Pang et al. 2009). The reason for this conclusion is that the most diversity of 
mtDNA was found here compared to all other dog populations surveyed (Pang et 
al. 2009).  On the other hand, according to genome-wide SNP and haplotype anal-
yses, the wolf was domesticated in the Middle East (von Holdt et al. 2010). Early 
after domestication, when the dog was spread worldwide, there was local inter-
breeding between the wolf and the dog and some dog breeds, like Alaskan Mala-
mute and Samoyed are two modern breeds resulting from such interbreeding. The-
se breeds are also called “ancient breeds” because they were founded over 500 
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years ago. Dog breeds that appear to have hybridized to the European Grey Wolf 
in modern days, according to genomic findings in genome-wide association stud-
ies, are Miniature Pinscher, Staffordshire Bullterrier, Greyhound and Whippet 
(von Holdt et al. 2010). 
The reason for why there are not more dog breeds today that have been 
mixed with wolves in modern days, even though the species co-exist, is probably 
the strict and controlled breeding practices founded in the Victorian era over one 
hundred and fifty years ago (von Holdt et al. 2010). Dogs have been clustered in 
10 groups (as suggested by Fédération Cynologique Internationale, FCI) of related 
breeds according to their geographic origin, morphology or function in human ac-
tivities (Kropatsch et al. 2011), and today there are more than 400 identified 
breeds of dogs (Clutton-Brock, 1999). 
2.2 Dogs and wolves as model species  
Genetic studies on dogs are performed both for the sake of the animals themselves 
and because they are important models for human disease (Galibert & André 
2008; Karlsson & Lindblad-Toh 2008). Genes of canids share 75% orthology with 
humans (Kirkness et al. 2004). The structure of the species is unique with exten-
sive Linkage disequilibrium (LD) within breeds, causing a reduced need of num-
ber of genetic markers to be used in genetic association studies. LD is when alleles 
at two or more loci exhibit non-random association. The degree of LD between 
breeds is very low and resembles that between different human populations. This, 
along with the shared environment with man, makes the dog a useful model for 
studying genetic diseases of humans (Lindblad-Toh et al. 2005; Galibert & André 
2008). 
Within dog breeds, LD is extensive because of the special way the breeds 
were created with two distinct bottlenecks (Ke et al. 2010). The first bottleneck 
occurred when the wolf was domesticated, and the other when the breeds were 
formed. Greater LD within breeds is caused by them being more genetically simi-
lar, or even inbred. Lesser LD between breeds is consequently due to the fact of 
there being less genetic similarity. In dogs, the LD ranges from hundreds of 
kilobases up to megabases, compared to humans where the LD is only around tens 
of kilobases (Lindblad-Toh et al. 2005). Ke et al. (2010) has shown that the dog 
that had the highest LD in the study of 19 dog breeds, Coyotes, Grey wolf and 
Ethiopian wolf, was the Boxer, with the Beddlington terrier as a close second. The 
lowest LD was exhibited by the coyote and the grey wolf, where the coyote sam-
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ples were taken from New Mexico and the wolf samples from isolated populations 
in Alaska and Northern Canada. As a result of the much more homogenous ge-
nome structure within dog breeds compared with human the number of Single Nu-
cleotide Polymorphisms (SNPs) needed to cover the entire genome in genome-
wide association is much smaller for the dog than humans (Lindblad-Toh et al. 
2005). 
2.3 Diseases and defects 
Defects that have been reported in wolves include transitional vertebra, which is 
an asymmetrical development of the vertebral body, bite defects, cryptorchidism 
and defects of the pulmonary system. These defects have also been found in dogs, 
and are in some cases heritable (Räikkönen et al. 2006, Report from SVA, 2010 & 
2011). It has been documented that wolves can be affected by at least seven virus-
es, 14 ectoparasites and 60 endoparasites. Of specific interest is rabies, Parvo vi-
rus, Sarcoptic mange (Sarcoptes scabiei) and Echinococcus. These pathogens have 
the potential to decimate the wolf population critically, and secondly, all except 
for Parvo virus are zoonotic (Kreeger 2003).  In Scandinavian wolves, a few cases 
of chronic joint inflammation have been reported (Report, SVA 2010).  
The effects of inbreeding that have been documented are lower first-year lit-
ter size and lower probability for adult wolves to enter the breeding population 
(Bensch et al. 2006). It has been reported that for every tenth the inbreeding coef-
ficient increases, the litter size decreases by 1.2 pups (Sand et al. 2010). In addi-
tion, the population has a higher frequency of congenital malformations than more 
outbred wolf populations such as the Finnish-Russian (Räikkönen et al 2006). 
2.4 Progressive Retinal Atrophy 
There are many types of inherited retinal degenerations in canids. Almost all of 
these retinal diseases cause dysplasia or degeneration of the rods and cones of the 
eye, leading to gradual loss of vision and eventually blindness. Collectively, these 
conditions are called progressive retinal atrophy (PRA), and are characterized by 
rod photoreceptor degeneration and deterioration of the cone photoreceptors. The 
homologous counterpart of PRA in humans is retinitis pigmentosa (Mellersh et al. 
2006; Miyadera et al. 2009). In 2009, 15 mutations in 11 genes reported to cause 
PRA were known in 34 breeds of dogs. Some breeds display multiple mutations 
leading to very similar PRA phenotypes (Miyadera et al. 2009).   
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2.4.1 Cord1 
One of the PRA diseases in dogs is the recessive cone – rod dystrophy (Cord1) of 
miniature longhaired dachshunds (MLHD), English springer spaniels, Beagles, 
French Bulldogs and Labrador retrievers (Miyadera et al. 2009). In this condition, 
which is implied by the name, there is primary cone degeneration followed by de-
struction of the rods. Cord1 is located on chromosome 15 (Cfa15) which carries a 
gene encoding for the retinitis pigmentosa GTPase regulator-interacting protein 
(RPGRIP1). In the affected breeds a nonsense mutation in the RPGRIP1 is associ-
ated with Cord1. Affected dogs have a 44bp insertion of 29 poly A’s followed by a 
duplication (GGA AGC AAC AGG ATG) of the 15 bp immediately upstream the 
poly A signal. The insertion is located in exon 2 which causes a frameshift and a 
premature stop codon located early in exon 3 that terminates translation of the 
mRNA, hence truncating the protein or nonsense mediated decay (nmd) (Mellersh 
et al. 2006; Miyadera et al. 2009).  
2.4.2 Prcd-PRA 
Another form of PRA is the late onset, autosomal recessive, rod-cone degeneration 
(Prcd-PRA) reported in more than 18 dog breeds (Zangerl et al. 2006). Early signs 
of the disease include pupil dilation, night blindness and increased reflectivity of 
the eye (Petersen Jones, 2005).  The Prcd gene has to date an unknown function 
and is located on canine chromosome 9. The disease is caused by a G to A transi-
tion at nucleotide 5 (of exon 1) of the coding sequence that results in a change of 
cysteine into tyrosine in the second amino acid (Zangerl et al. 2006). 
2.4.3 Gr_PRA1 
Gr_PRA1 is another type of PRA is a late onset disease (diagnosis at ~6 years of 
age) found in Golden Retrievers. Gr_PRA1 is caused by a frameshift mutation in 
the solute carrier anion exchanger gene SLC4A3 on chromosome 37. The mutation 
is thought to be caused by a cytosine insertion in exon 16 which is predicted to 
cause a premature stop codon in exon 18. The premature stop is considered to ei-
ther yield a truncated protein or cause degradation of the mRNA (Downs et al. 
2011). 
2.4.4 Type-A PRA 
A mutation in the phosphoducin (PDC) gene causes an autosomal recessive form 
of PRA (Type-A PRA). The mutation gives rise to a disease that is initialized by 
loss of night sight followed by loss of sight at daytime caused by abnormal devel-
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opment of photoreceptors (Zhang et al. 1998). Phosphoducin is a phosphoprotein 
found in the cytosol of the photoreceptor cells of the retina and pineal gland (Abe 
et al. 1994). The disease is caused by a C to G transversion at nucleotide 244 lead-
ing to an arginine to glycine substitution at codon 82 (Zhang et al. 1998).  
2.5 PLL 
Primary lens luxuation (PLL) is a displacement of the lens of the eye, ectopia 
lentis, and has many possible etiologies. The disorder is very painful, and although 
not a type of PRA it leads to blindness and is common in many breeds of terriers, 
but has been reported in 85 different breeds of dogs (Sargan et al. 2007). One form 
is caused by a mutation in the gene ADAMTS17 that belongs to a family of genes 
encoding for metalloproteases that modifies extracellular proteins.  The disease 
has similar genetic etiology as the human disease Weill-Marchesani syndrome 
(WMS) (Ahram et al. 2009). PLL has been recognized by veterinary medicine for 
over 75 years and it has several different, both genetic and environmental, causes. 
At 3-8 years of age luxation occurs (Curtis 1980) but ultrastructural abnormalities 
can be seen as early as 20 months of age (Curtis 1983). The responsible mutation 
is located in the splice donor site of exon 10 and is a G to A transition that causes 
destruction of the splice donor recognition site. Mutation of the transcript of 
ADAMTS17 causes it to lack exon 10 and to give rise to a frameshift and a result-
ing downstream premature stop codon (Farias 2010).  
2.6 MHC 
The major histocompatibility complex (MHC) is a genomic region with genes in-
volved in the adaptive immune system. MHC codes for three classes of proteins 
where class I and II molecules are antigen presenting glycoproteins. Class I mole-
cules are present on all somatic cells but class II molecules are only found on pro-
fessional antigen presenting cells such as macrophages, B-lymphocytes and den-
dritic cells (Trowsdale 1995, Wagner 1999, Berggren & Seddon 2005). Presenta-
tion of antigens to T-cells leads to, among other processes, elimination of infected 
cells.  
Class I and II molecules exhibit extensive polymorphism. It is thought that a large 
variation of the class I and II genes provides better protection against pathogens 
since they will have a greater probability of presenting a wider range of antigens 
(Hedrick 1999). An heterozygous individual would therefore have a higher fitness 
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than homozygous individuals (heterozygous advantage) (Hedrick 1999). The 
MHC class II genes in canids include DLA-DRB1, DLA-DQB1, DLA-DRA, and 
DLA-DQA1. Exon 2 of the DLA-DRB1, DLA-DQB1 and DLA-DQA1 genes en-
codes the antigen-binding pocket and display most polymorphisms, whereas DLA-
DRA has no variation (Wagner et al. 1999). 
In wolves from Ethiopia (C. simensis) MHC class II haplotypes of exon 2 
were tested for their susceptibility for rabies and the effect of rabies vaccination. 
Kennedy et al. (2011) hypothesized that the MHC indeed might influence the re-
sponse to vaccination. It was shown that one haplotype was associated with a low-
er response. This would be interesting to define in the Scandinavian wolf popula-
tion since one concern with moving wolves from Russia to Sweden is that they 
will transfer rabies into the country. It would be practical to test the prospective 
wolf haplotypes and with the result decide whether they are suitable for movement 
or not. 
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3 Material and methods 
3.1 The studied dog population 
A summary of all the dogs that were used for controls can be seen in appendix 1. 
The dogs were chosen for their clinical diagnosis and their availability in the la-
boratory. 
3.2 The studied wolf population 
The samples from the wolves were taken either from dead animals after hunting, 
during autopsy, or from live animals during marking. The samples included in the 
study, were taken from 23 Scandinavian wolves in Sweden and Finland between 
the years 1977 until 2011. They were chosen in such a way that the total variation 
of the present population would be captured. This was possible since only three 
individuals and two later immigrants founded the current Scandinavian population. 
In Table 1 all the sampled wolves along with important information, such as iden-
tity, type of tissue and gender can be viewed.  
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Table 1. Table of all the sampled wolves, where one wolf (V14) had an unknown year of death 
 
3.2.1 DNA extraction  
DNA was extracted from 200 µl blood and tissue (8mm3) using a 
fenol/chloroform-isoamylalcohol protocol (Sambrook et al. 1989) at Grimsö 
forskningsstation (Örebro, Sweden)  and sent by mail to Ultuna (Uppsala). The 
concentration and quality of the DNA was measured by NanoDrop ND-8000.  
3.2.2 PCR 
All DNA amplifications were performed using the GeneAmp 9700  (Applied-
Biosystems, Foster City, CA USA). For reaction conditions see below. 
3.3 Monogenic tests 
All the primers and probes that were used in this study are defined in Table 2 and 
3, respectively. These specific tests were chosen since they were possible to per-
form in the time frame of this study. 
Id Identity Type Sex Y. O. D Comment
V1 D-77-01 Tissue M 1977 Immigrant, no surviving offspring
V2 D-79-01 Tissue F 1979 Immigrant, no surviving offspring
V3 D-84-03 Tissue M 1984 Offspring Nyskoga 1 couple
V4 D-85-01 Tissue F 1985 Immigrant, Alpha-female Nyskoga 1
V5 D-85-02 Tissue M 1985 Offspring to Nyskoga 1 couple
V6 D-86-01 Tissue M 1986 Offspring to Nyskoga 1 couple
V7 D-92-01 Tissue M 1992 Offspring to Gillhov couple
V8 D-92-02 Tissue M 1992 Offspring to Gillhov couple
V9 D-92-03 Tissue M 1992 Offspring to Gillhov couple
V10 D-93-01 Tissue M 1993 Offspring to Gillhov couple
V11 D-96-01 Tissue M 1996 Offspring to Gillhov couple
V12 SFT13087 Tissue M 1997 Shot in Finland
V13 SF230 Tissue M 1998 Shot in Finland
V14 M-98-03 Blood F ? Offspring to Gillhov couple
V15 D-99-02 Tissue M 1999 Offspring to Gillhov couple
V16 M-02-15 Tissue M 2003 Immigrant, non reproducing
V17 D-04-13 Tissue F 2004 Offspring Gillhov couple
V18 D-05-18 Tissue M 2005 Immigrant, non reproducing
V19 M-07-02 Blood M 2008 Immigrant, non reproducing
V20 M-09-03 Blood M Alive Immigrant and Alpha male in Galven
V21 M-10-20 Tissue M Alive Immigrant and Alpha male in Kynna 2
V23 G82-10 Blood F Alive Immigrant 2010, 
V24 D 91-01 Blood F 1991 Offspring Nyskoga 2
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3.3.1 Cord1 
PCR amplification 
PCR was performed according to a protocol developed by the author. The reaction 
was performed with 0.5 µl of 20 ng/µl of DNA in a 10µl reaction. The reaction 
contained 1µl 10xPCR Buffer without MgCl2 (Invitrogen, Carlsbad, CA, USA), 1 
µl MgCl2 (25 mM), 0.5 µl of each primer (10 µM,) 0.1 µl of dNTP (25 mM free 
nucleotides), 6,3 µl ddH2O and 0,1 µl Ampli Taq Gold (5 U/µl). A PCR protocol 
was used with an initial denaturation temperature of 94°C for 5 min. It was fol-
lowed by 35 cycles of denaturation at 94°C for 1 min, then 40 seconds of anneal-
ing at 60°C and extension 72°C for 40 seconds and then a final extension at 72°C 
for 7 min.  
Table 2. Primer sequences of the performed PCR reactions 
Data analysis 
For the Cord1 mutation the alleles of interest were run by using capillary electro-
phoresis (ABIPrism 3100 Genetic Analyzer, CA, USA) with a 400HD ROX Size 
Standard template and the acquired data analyzed by GeneMapper 4,0 
(AppliedBiosystems). The samples were run with English springer spaniels as 
controls, see appendix. 
3.3.2 SLC4A3 
PCR was performed according to a protocol developed by Louise M Downs (Ge-
netics Department, Animal Health Trust, Newmarket, UK) (Downs et al. 2011). 
The reaction was performed with 0.5 µl of 20 ng/µl of DNA in a 7.5 µl reaction. 
The reaction contained 1.5µl 5xHotStarPCR Buffer (dNTPs + MgSO4 (Qiagen, 
Valencia, CA, USA), 0.5 µl of each primer (10 µM) 0.1 µl of dNTP (25 mM free 
nucleotides), 4.45 µl ddH2O and 0,1 µl HotStar Polymerase (Qiagen) standard 
PCR protocol with 25 cycles was used with an initial denaturation temperature of 
94°C for 10 min. It was followed by denaturation at 94°C for 1 min, then 60 se-
Sequence Forward Reverse T7
DRB1 CCGTCCCCACAGCACATTTC TGTGTCACACACCTCAGCACCA TAATACGACTCACATATAGGG
DQA1 TAAGGTTCTTTTCTCCCTCT GGACAGATTCAGTGAAGAGA TAATACGACTCACATATAGGG
DQB1 CTCACTGGCCCGGCTGTCTC CACCTCGCCGCTGCAACGTG TAATACGACTCACATATAGGG
SLC4A3 AGAGCAACCTTGTAACCCGTA GGAAGAAGGCAATGAGAAAGG
RPGGRIP1 CCCTTTCCTGGGACTTTAGG CCCTCTGCCTATGTCTCTGC
PDC GTCTATTCCCAGATGAGCATTCAAGA CCTGCATACATTGTCTACGATATTTACGA
Prcd CCTTTCTCCTGCAGACTCTGT CCAAGGTGCTGAGTAGGAAGAG
ADAMTS17 CACCAACGCCACCTTCTG GATGCTCCTTCCTGTGTCAGT
Primers 
 17 
conds of annealing at 60°C and extension 72°C for 2 min. and then a final poly-
merase inactivation at 94°C for 10 min. 
Data analysis 
The SLC4A3 mutation were analyzed using the ABIPrism 3100 Genetic Analyzer 
using a 400HD ROX Size Standard and the aquired data analyzed by GeneMapper 
4,0 (Applied-Biosystems). The samples were run with Golden retrievers and Field 
spaniels as controls, see appendix. 
3.4 TaqMan 
All TaqMan real-time PCRs used in this study were performed in the same way as 
described for PLL. 
Table 3. Probe sequences for TaqMan runs 
3.4.1 PLL 
The allelic discrimination was performed by real-time PCR  with custom made 
SNP genotyping assays (Applied Biosystems) using the TaqMan StepOnePlus. 
Each 20µL reaction contained 10µl of TaqMan Genotyping mastermix (Applied 
Biosystems), 0.5µl of Assay Mix, 2µl DNA template and 7.5 µl of ddH2O. 
 The PCR started with a denaturation step of 10 min at 95°C, and was fol-
lowed by 40 cycles of 95°C for 15 s and 60°C for 1 min. 
The wolf samples were run with miniature bull terriers and Lancarshire heelers as 
controls, see appendix. 
 
3.4.2 Type-A PRA 
The same real time PCR method as for ADAMTS17 was used. The wolf samples 
were run with miniature schnauzers as controls, see appendix. The PCR product 
was tagged with M13 uni(-21) and M13 rev(-29) for sequencing. 
Sequence VIC FAM
PDC TTCTTTGTCTCGGTGAATT TCTTTGTCTCCGTGAATT
Prcd TGAGCCATGTGCACCAC TGAGCCATGTACACCAC
ADAMTS17 AAACATGGAGATAAGCAG ACATGGAGGTAAGCAG
Probes
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Sequencing preparation –ExoSAP IT 
To perform sequencing the primers and dNTPs had to be removed and this was 
performed with ExoSap IT (Affymetrix, Santa Clara, CA, USA). 2µl of ExoSAP 
IT was added to 5µl of PCR product and this was run on a simple PCR program at 
37°C for 15 min, where the primers and dNTPS are removed, and then 85°C for 
15 min to inactivate ExoSAP. After this 20µl of ddH2O was added and 2*3µl was 
transferred to two wells on a new plate. After this 3µl of M13 uni(-21) and rev(-
29) was added to half the wells, respectively. 3 µl of a concentrated stock solution 
(5M) was added to each well and then diluted with addition of 12µl ddH2O. 
Sequencing 
The prepared samples were sent for sequencing to Uppsala genome center 
(Rudbeckslaboratoriet, Uppsala University). 
 
3.4.3 Prcd-PRA 
The same real time PCR method as for ADAMTS17 was used. The samples were 
run with English springer spaniels, Labrador retrievers and Chinese crested as con-
trols. 
 
3.5 DLA 
3.5.1 PCR amplification and sequencing 
PCR was performed according to a protocol developed by Maria Wilbe (Wilbe et 
al. 2009), Dept. Animal Breeding and Genetics, SLU. The reaction was performed 
with about 20 ng of DNA in a 20µl reaction. The reaction contained 2µl 10xPCR 
Buffer without MgCl2 (Invitrogen), 1.2 µl MgCl2 (25mM), 0,5 µl of each primer 
(10µM) 0.2 µl of dNTP (20 mM free nucleotides), 13.46  µl ddH2O and 0.14 µl 
Ampli Taq Gold (5 U/µl). T7 was used for labeling the PCR products. A touch-
down PCR protocol was used with an initial temperature of 95°C for 15 min, 14 
touchdown cycles of 95°C for 30 seconds, followed by 1 min of annealing starting 
at 62°C (DRB1), 54°C (DQA1) and 73°C (DQB1). This was followed by 20 cycles 
of 95°C for 30 seconds, 55°C (DRB1), 47°C (DQA1) and 66°C (DQB1) for 1 min, 
72°C for 1 min and a final extension at 72°C for 10 min. 
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To perform sequencing, the primers and dNTPs had to be removed and this was 
performed with ExoSap IT (Affymetrix). 2µl of ExoSAP IT was added to 5µl of 
PCR product and this was run on a simple PCR program at 37°C for 15 min, 
where the primers and dNTPS are removed, and then 85°C for 15 min to inactivate 
ExoSAP. After this 20µl of ddH2O was added and 3µl was transferred to a new 
plate. After this 3µl of T7 (5M) sequencing primer was added to each well and 
then 12µl of additional ddH2O was added to further dilute the samples. The pre-
pared samples were sent for sequencing to Uppsala genome center 
(Rudbecklaboratoriet, Uppsala University).  
3.5.2 Sequence analysis 
The acquired sequences were analyzed using the Macintosh software Match Tools 
and Match Tools Navigator (Applied-Biosystems). First the sequences of exon 2 
were compared to a consensus sequence in Match Tools Navigator, where each 
polymorphic site was manually viewed and corrected if necessary. After this the 
corrected sequence was uploaded into Match Tools where it was automatically 
compared to a reference sequence library and the program provides a call for the 
matching allele. The nucleotide and peptide sequences were aligned in ClustalW 
(http://www.ebi.ac.uk/Tools/msa/clustalw2). TranSeq in EMBOSS was used for 
finding the protein and ORF of the nucleotide sequences 
(http://www.ebi.ac.uk/Tools/emboss/transeq for the peptide sequence. The haplo-
types were assumed by the method of “three locus haplotypes” as described by 
Kennedy et al. (2002). The haplotype construction was based firstly on observing 
homozygotes and secondly on the assumption that there is minimal recombination 
between DQA1 and DQB1. 
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4 Results 
4.1 Gel electrophoresis 
To ensure that proper PCR protocols were used for Cord1, SLC4A3 and DLA all 
the reactions were run on an agarose gel. A picture of a gel run of Cord 1 can be 
seen in Figure 1 and a picture of a gel run of DLA can be seen in Figure 2. 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Agarose gel electrophoresis of the Cord1 mutation with samples of a (left to right) 
Normal (ESS-005), Carrier (ESS-006) and Affected (ESS-014) individual. 
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Figure 2. Agarose gel electrophoresis of the DRB1, DQA1 and DQB1 alleles in three Golden 
retrievers and two wolves. The DRB1 allele was run farthest to the left with the three first 
samples being dogs (GR226, GR227, GR228) and the two last samples being wolves (V16, 
V18). The same setup was applied for the DQA1 allele and the DQB1 allele. 
4.2 Genotyping by sequencing of MHC class II 
 
In Table 4 the result of the DLA sequencing of exon 2 of each wolf can be seen 
along with their corresponding haplotypes. A list of the eight haplotypes and the 
alleles included is illustrated in Table 6. One wolf, V18, Table 5, was excluded 
from Table 4 since it was the only one carrying these specific alleles making it 
impossible to construct haplotypes by the method of three locus haplotypes. Eight 
different alleles were found at the DRB1 loci, six at DQA1 and seven DQB1.  
Samples V1 and V2 were derived from animals killed in northern Sweden be-
fore the now established population existed. V4 is the female that founded the now 
existing population and V3, V5, V6 are its offspring. V24 is the offspring of two 
siblings from the Nyskoga 1 couple. All the offspring to the Gillhov couple are 
descendants of the original Nyskoga 1 couple. V1, V2, V16, V19 and V22 have 
not (yet) contributed to the genetic variation of the Swedish wolf population. Thus, 
the Scandinavian wolf population, according to these results, has five assumed 
DLA class II haplotypes. Additionally, this means that there are only four DRB1 
alleles, three DQA1 alleles and four DQB1 alleles in the present Scandinavian 
wolf population. 
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Table 4. The wolves and their corresponding haplotypes organized according to relationship to 
eachother. Allele DQA1*012011 was previously called DQA1*01201 
 
Table 5. The alleles of the wolf with unique DLA-genotypes. 
 
Table 6. The eight different haplotypes and their respective alleles. 
Haplotypes DRB1 DQA1 DQB1 
1 04901 005011 03901 
2 03101 01101 04001 
3 03101 005011 03901 
4 03601 012011 03501 
5 05401 00301 00401 
6 02901 00301 00401 
7 05301 00301 00401 
8 05301 01101 01303 
ID Status DRB1 DQA1 DQB1 DRB1 DQA1 DQB1
V1 Immigrant, no offspring survived 02901 00301 00401 04901 05011 03901
V2 Immigrant, no offspring survived 03101 01101 04001 03101 01101 04001
V4 Immigrant, Alpha-female Nyskoga 1 03101 01101 04001 03101 005011 03901
V5 Offspring Nyskoga 1 couple 03101 01101 04001 03101 01101 04001
V6 Offspring Nyskoga 1 couple 03101 01101 04001 03101 01101 04001
V3 Offspring Nyskoga 1 couple 03101 01101 04001 04901 05011 03901
V24 Offspring Nyskoga 2 03101 005011 03901 04901 05011 03901
V9 Offspring Gillhov couple 04901 05011 03901 04901 05011 03901
V14 Offspring Gillhov couple 04901 05011 03901 04901 05011 03901
V15 Offspring Gillhov couple 04901 05011 03901 04901 05011 03901
V7 Offspring Gillhov couple 04901 05011 03901 04901 05011 03901
V17 Offspring Gillhov couple 04901 05011 03901 04901 05011 03901
V8 Offspring Gillhov couple 04901 05011 03901 04901 05011 03901
V10 Offspring Gillhov couple 03101 01101 04001 04901 05011 03901
V20 Immigrant and Alpha male in Galven 03601 012011 03501 05301 01101 01303
V21 Immigrant and Alpha male in Kynna 2 03601 012011 03501 03601 012011 03501
V16 Immigrant, non reproducing 03601 012011 03501 05401 00301 00401
V22 Immigrant 2010 03601 012011 03501 04901 05011 03901
V19 Immigrant, non reproducing 03101 01101 04001 05301 00301 00401
ID DRB1 DQA1 DQB1 DRB1 DQA1 DQB1
V18 05601 01001 05601 02002 014012 04401
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The most common genotype found in the study population of Swedish wolves, 
illustrated in Table 7, was homozygosity of haplotype 1, and was carried by 
31,6%. The second most common form was also a homozygous form, but of hap-
lotype 2 carried by 15,8% of the study population. These numbers does not carry 
any significance though, as the study population includes many offspring due to 
the lack of sampling of parents. 
Table 7. The different genotypes and their frequency in the population 
  
The frequency of the different DLA class II alleles can be seen in Tables 8-10. 
Two DRB1 alleles are more common in the population, DRB1*04901 was found 
in 42,5% and DRB1*03101 was found in 30%. For DQA1, 005011 (47,5%) and 
01101 (27,5%) was the most common and for DQB1, 03901 (47,5%) and 04001 
(25%) was the most common.  Again this was due to the sampling of many off-
spring. 
Table 8. The frequency of the different DRB1 alleles within the study population 
Genotypes N Frequency %
1,1 6 31,6
1,2 2 10,5
1,3 1 5,3
1,4 1 5,3
1,6 1 5,3
2,2 3 15,8
2,3 1 5,3
2,7 1 5,3
4,4 1 5,3
4,5 1 5,3
4,8 1 5,3
 24 
 
Table 9. The frequency of the different DQA1 alleles within the study population 
 
Table 10. The frequency of the different DQB1 alleles within the study population 
 
A pedigree for the Scandinavian wolf population based on the study population 
(Liberg et al. 2005) and their haplotypes were constructed and are shown in Figure 
3. In the 1980’s two immigrants founded the population that exists today, out of 
this couple only one (the female) is sampled, V4. These two individuals were car-
rying three haplotypes out of four possible (four chromosomes). On these three 
haplotypes they carried with them two different DRB1 alleles, two DQA1 alleles 
and two DQB1 alleles. The third immigrant (not sampled) that entered the Scandi-
navian population in the 80’s did not carry any new alleles. Two male immigrants 
DRB1 N (40) Frequency %
04901 17 42,5
03101 12 30
03601 5 12,5
05401 1 2,5
02901 1 5
05301 2 2,5
05601 1 2,5
02002 1 2,5
DQA1 N (40) Frequency %
005011 19 47,5
01101 11 27,5
012011 5 12,5
00301 3 7,5
01001 1 2,5
014012 1 2,5
DQB1 N (40) Frequency %
03901 19 47,5
04001 10 25
03501 5 12,5
00401 3 7,5
01303 1 2,5
05601 1 2,5
04401 1 2,5
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entered the reproductive population in 2008 (V20, V21) and carried two new hap-
lotypes that were introduced, giving the population well needed addition of two 
new alleles at every DLA class II locus. Two other males (V16, V19) immigrated 
into Sweden in the first decade of the 21st century but did not get a chance to re-
produce resulting in a loss of valuable alleles. These two carried with them two 
new DRB1 alleles. In 2010, a female wolf immigrated. This was the first female 
since the founder couple to enter Sweden without being quickly killed. This fe-
male did unfortunately not carry any new DLA alleles. 
 
 
Figure 3. A pedigree of the wolves sampled for MHC class II analysis. 
All the DLA alleles found in this study has previously been reported in wolves and 
most of them have previously also been found in dogs, only five have not. A 
summary of which alleles that are exclusive to wolves is shown in Table 11. 
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Table 11. The DLA-alleles found in this study compared to their existence in dogs (Seddon & 
Ellegren 2002, Seddon & Ellegren 2004 Kennedy et al. 2001, Kennedy et al. 2007a, 2007b) 
 
 
 
 
 
 
 
Allele Dog Grey Wolf
DRB1*02002 * *
DRB1*02901 * *
DRB1*03101 *
DRB1*03601 *
DRB1*04901 * *
DRB1*05301 * *
DRB1*05401 * *
DRB1*05601 * *
DQA1*005011 * *
DQA1*00301 * *
DQA1*01001 * *
DQA1*01101 *
DQA1*012011 * *
DQA1*014012 *
DQB1*00401 * *
DQB1*01303 * *
DQB1*03501 * *
DQB1*03901 * *
DQB1*04001 *
DQB1*04401 * *
DQB1*05601 * *
Found in
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An alignment of the amino acid sequences and nucleotide sequences for the identi-
fied DLA class II alleles in wolves are shown in Figures 4-9.  
 
Figure 4. Amino acid alignment of the found DLA-DQA1 alleles  
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Figure 5. Nucleotide alignment of DQA1. 
At the hypervariable region 1 (HVR 1) only DQA1*005011 differs and has a phe-
nylalanine instead of a tyrosine caused by an A T transversion. At HVR-2 there 
are three different amino acids, threonine (hydrophilic), arginine and alanine. In 
DQA1*012011 an AG transition causes a change into alanine.  In 
DQA1*014012 and *01001 a CG transition causes the change into arginine. 
HVR 3 is more polymorphic with five different sites showing polymorphism. The 
first site is the first amino acid of HVR 3 and has two forms; isoleucine (hydro-
phobic) or arginine. A CT transition and two bases further down a GT 
transversion in DQA1*00301 is responsible for the change into arginine. The se-
cond amino acid has three forms threonine, isoleucine and alanine caused by an 
AT and CG transition in two adjacent bp.  The third site is the ninth amino 
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acid which has two forms leucine and methionine caused by an AC transversion 
in DQA1*00301 and *01001. Three amino acids further down the site exhibits two 
forms; arginine and serine caused by a GT transversion in DQA1*00301 and 
*01001. The last amino acid of HVR 3 has two forms; lysine and glutamine 
caused by a CA transversion in DQA1*005011 and *01101.   
 
Figure 6. Amino acid alignment of the identified DLA-DQB1 alleles  
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Figure 7. Nucleotide alignment of DQB1. 
In HVR 1 of DQB1 there are two polymorphic sites. The first site has two differ-
ent amino acids; tyrosine and phenylalanine. The change in amino acid is caused 
by a TA transition in DQB1*04401, *03901 and *00401. The second polymor-
phic site in HVR 1 has three different amino acids; phenylalanine, alanine, and 
glycine caused by a GT transversion and a C (DQB1*04401), G, T polymor-
phism in two adjacent bp. In HVR 2 there are four polymorphic sites. The first site 
carries two different amino acids; alanine and threonine, which is caused by a 
GA transversion in half of the alleles. The next site is adjacent to the first and 
also has two different amino acids; arginine and lysine which is caused by a GT 
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transversion. The next site after that is also adjoining and has three polymor-
phisms; aspartic acid, asparagine and tyrosine caused by a G, A (DQB1*05601) 
and T polymorphism. The last amino acid in HVR 2 has a triple polymorphism; 
histidine, phenylalanine and tyrosine caused by a polymorphism of the triple co-
don in the second and third position. Three alleles have GCA  (DQB1*03501, 
*04401, *04401), three have GTT (DQB1*05601, *01303, *03901) and one GTA 
(DQB1*00401). HVR 3 has 10 polymorphic sites out of 19 possible, making it 
complicated to decide what nucleotide mutation that is causing which amino acid 
change. 
 
 
Figure 8. Amino acid alignment of the identified DLA-DRB1 alleles  
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Figure 9. Nucleotide alignment of DRB1. 
HVR 1 and HVR 2 of DRB1 has six polymorphic sites, and HVR 3 has eight mak-
ing it very complicated to decide which base pair substitution that is causing what 
amino acid change. 
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4.3 Monogenic tests 
All the wolves were tested normal for all the diseases studied in this project. A 
summary of the results for all wolves can be seen in Table 13. The dogs used as 
controls can be seen in the appendix along with their breeds and genotypes for the 
different tests. 
Table 13. The results of all the monogenic tests for eye diseases in wolves. Individuals denoted by ? 
have an unknown genotype for that gene 
 
 
4.3.1 Gr_PRA1 
When the genotyping result from the ABIPrism 3100 was analyzed with 
GeneMapper 4.0 (AppliedBiosystems) the picture in Figure 10 was acquired. The 
wolf samples were run against three Golden Retrievers used for routine testing and 
all wolves appeared to be normal at the SLC4A3 loci. 
Id Identity Prcd SLC4A3 RPGGRIP1 ADAMTS17 PDC
V1 D-77-01 Normal Normal Normal Normal Normal
V2 D-79-01 Normal Normal Normal Normal Normal
V3 D-84-03 Normal Normal ? Normal Normal
V4 D-85-01 Normal Normal Normal Normal Normal
V5 D-85-02 Normal Normal Normal Normal Normal
V6 D-86-01 Normal Normal Normal Normal Normal
V7 D-92-01 Normal Normal Normal Normal Normal
V8 D-92-02 Normal Normal ? Normal Normal
V9 D-92-03 Normal Normal Normal Normal Normal
V10 D-93-01 Normal ? Normal Normal Normal
V11 D-96-01 Normal Normal Normal Normal Normal
V12 SFT13087 Normal Normal ? Normal Normal
V13 SF230 Normal Normal ? Normal Normal
V14 M-98-03 Normal Normal Normal Normal Normal
V15 D-99-02 Normal Normal Normal Normal Normal
V16 M-02-15 Normal Normal Normal ? Normal
V17 D-04-13 Normal ? Normal Normal Normal
V18 D-05-18 Normal Normal Normal Normal Normal
V19 M-07-02 Normal Normal Normal Normal Normal
V20 M-09-03 Normal Normal Normal Normal Normal
V21 M-10-20 Normal ? Normal Normal Normal
V23 G82-10 Normal ? Normal Normal Normal
V24 D 91-01 ? ? Normal ? Normal
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Figure 10. Screenshot from GeneMapper showing the result if the analysis of the SLC4A3 
gene for the controls. GR 109 was homozygous affected, GR 305 was a carrier and GR326 
was a homozygous normal. The four wolf samples included here were all normal. 
4.3.2 Cord1 
The analysis of the Cord1 mutation of wolves provided Figure 11. The wolf sam-
ples were run against three English springer spaniel controls and all wolves ap-
peared to be normal at the Cord1 loci. 
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Figure 11. Screenshot from GeneMapper showing the result if the analysis of the Cord1 gene 
for the controls and a few wolf samples that tested normal. 
4.4 TaqMan 
4.4.1 Type-A PRA 
The wolves were run on a TaqMan genotyping assay for PDC against four minia-
ture schnauzer controls. All the wolves appeared to be normal as can be seen in 
Figure 12. To ensure that the primers were correct, sequencing was performed on 
two wolves. The region of the PDC gene containing the mutation of interest can be 
seen in Figure 13 showing that the correct primers indeed had been used. 
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Figure 12. Allelic 
discrimination plot of 
TaqMan run of the 
PDC gene. All 
wolves (V1-V24) 
were homozygous 
normal (Al-
lele1/Allele1). Posi-
tive control for carri-
ers were dvs07 and 
dvs09  and controls 
for affected were 
dvs02 and dvs05. 
 
 
 
 
 
 
Figur 1.  
Figure 13. The region of the PDC se-
quence containing the nucleotide 
change (G to C) in a heterozygote 
(dvs09), a homozygote affected 
(dvs05) and two homozygous normal 
wolves (V18, V16). 
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4.4.2 Prcd-PRA 
The wolves were run on a TaqMan genotyping assay for Prcd against three Labra-
dor retriever controls. A synthetic carrier was constructed by mixing equal 
amounts of DNA templates from the Affected dog L1 and the Normal dog L2. 
L3was used as a normal control. All the wolves appeared to be normal as can be 
seen in Figure 14. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 14. Allelic discrimination plot of the Prcd gene. All wolves  (V1-V22/23) were homozy-
gous unaffected (Allele2/Allele2). Positive controls for affected was L1, for Carrier a L1/L2 
mix was used and for a Normal control L3 was used. 
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4.4.3 PLL 
The wolves were run on a TaqMan genotyping assay for ADAMTS17 against six 
controls from the breeds Miniature bull terrier and Lancashire heeler. All the 
wolves appeared to be normal as can be seen in Figure 15. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figur 15. Allelic discrimination plot of TaqMan run of the ADAMTS17 gene. (V1-V22/23) were 
homozygous unaffected (Allele 2/Allele2). Positive control for carriers were 4574 and 5313, 
controls for affected were 5479 and 5675, and controls for Normal were 6855 and 7020. 
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5 Discussion 
5.1 Monogenic tests 
Several disease-causing mutations have been found in dogs. As dogs have a com-
mon origin with the wolf, it may be possible that some of the disease-causing al-
leles were already present in the wild ancestor before the divergence. Even though 
the wolves were normal for all the gene tests employed in this study it does not 
exclude the possibility that they may carry other mutations responsible for the 
blindness seen in captive wolves reported by Laikre et al. (1993). We did not ex-
pect to find any genetically affected wolves by these eye diseases because it most 
likely would have affected the longevity of the animals in the wild if they were 
blind, and thus this would have been reported before. However, we wanted to ex-
amine the possibility that there are carriers in the population. Also, only very few 
of the possible mutations were tested for. A large part of the population probably 
would have been affected or carriers given that many are closely related (Vila et 
al. 2003). The wolves in captivity today are presumably not closely related to the 
now existing Scandinavian population due to that they were captured in the wild 
before the now existing wild population (Laikre et al 1993). For future research, 
the wolves in captivity could (or could?) be tested for all genetic eye diseases re-
ported in dogs. If no tests will come out positive there might be a new mutation 
causing the blindness. This should then be studied which could be valuable not 
only for the sake of the captive wolves but for human and veterinary medicine as 
well. If the wolves carry a known mutation more knowledge of this mutation could 
be gained because the population is so closely related. Closely related individuals 
tend to express disease mutations in higher frequency.  
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5.2 MHC polymorphism 
Inbreeding reduces the genetic variation in a population, and variation at the MHC 
loci is essential for effective immunity, and thus inbreeding could be thought to 
decrease the variation at the MHC loci (Hedrick 1999). In the surveyed population 
eight MHC haplotypes were found. In 80 dog breeds surveyed by Kennedy et al. 
(2002) 58 haplotypes were found and 28 haplotypes in North American grey 
wolves were reported by Kennedy et al. (2007c). In a common dog breed, such as 
the Golden Retriever, eight DRB1 alleles, nine DQA1 alleles and seven DQB1 
alleles have been identified (Kennedy et al. 2002). In this study, eight DRB1 al-
leles, six DQA1 alleles and seven DQB1 alleles were found in the total study pop-
ulation, which is almost the same amount. In a more inbred dog breed, like the 
Cocker Spaniel, only five of each DLA allele has been identified. In the Scandina-
vian reproductive population today, there are five haplotypes with four DRB1 al-
leles, three DQA1 alleles and four DQB1 alleles which is roughly half of the 
amount observed in Golden Retrievers. This indicates that the Scandinavian popu-
lation has approximately half the variation of a normal population, if dog breeds 
can ever be considered as a normal population (Kennedy et al. 2002).  
The wolves that were killed before entering reproduction (V1, V16, V19), 
carried new DLA alleles. Because these wolves were lost, the Scandinavian popu-
lation never acquired four possible new DRB1 alleles (*02901, *05401, *05601, 
and *02002) three DQA1 alleles (*00301, *01001, and *014012) and three DQB1 
alleles (*00401, *05601, and *04401). Perhaps a better way than license hunting 
(although no wolves in this study wolves were killed by license hunting) would be 
to sample wolves, possibly for analysis of DLA variation, and then from the result 
of this deduce what wolves should be humanely euthanized. DLA could in this 
way be used as a sort of marker for genetic variation. This also means that there 
needs to be a library for reference on existing DLA alleles in the Scandinavian 
population. Whether MHC diversity is essential for reproductive success or not 
has been debated since there are some wildlife species with little variation that are 
viable and yet others that are not (Kennedy et al. 2007c). Given this, one cannot be 
absolutely certain in concluding that wolves are in need of greater genetic varia-
tion at the MHC class II loci. 
It is possible that the findings in this study mean that wolves because of the 
inbreeding have become less resistant to pathogens. For future research it would 
be very interesting to sample genotypes from wolves that have succumbed to dif-
ferent pathogens to see if they have little MHC variation. These findings could 
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then be crosschecked against their haplotypes to see what haplotypes cause a sus-
ceptibility to different pathogens. In the extension this could be beneficial for hu-
man medicine as well. 
In April 2011 an offspring to V20 was moved because it was killing reindeers 
and causing trouble for the farmers in Norrbotten (Naturvårdsverket, 2011a). After 
analyzing the DLA alleles of V20 we can conclude that this was a good choice 
from a MHC-perspective, since it carried valuable alleles, where one was unique 
to the Scandinavian population, DQB1*01303.  
The newly immigrated female (V23) carries DLA alleles already present in 
the Scandinavian population, but is still valuable because of other yet to be defined 
genetic variation it may carry. Specifically, no new mtDNA has entered the breed-
ing population since the first founder couple, which is why this particular wolf is 
so valuable. Mitochondrial DNA is only transferred from females. MtDNA en-
codes for genes responsible for converting chemical energy into ATP, the energy 
of choice for eukaryotic cells. Accumulation of deleterious genes in mtDNA can 
therefore be thought as harmful. It can thus be deduced that moving this immigrant 
from Jämtland to Örebro in march 2011 (Naturvårdsverket, 2011b) was the correct 
course of action. 
The wolf that had entirely different DLA alleles than the rest of the studied 
population (V18) may originate from a completely different location than the other 
sampled wolves. It was shot in Finnmark, which is a region including Norway 
north of Lofoten and Swedish and Finnish Lappland. This wolf would have been 
very valuable to integrate into the breeding population because of its unique al-
leles. 
The wolves in the present Swedish population are thought to have immigrat-
ed from the Finnish/Russian population. When comparing DLA alleles reported in 
Russian wolves with the alleles from this study the following alleles have not been 
reported in Russia; DRB1*02002, DRB1*03101, DRB1*03601, DRB1*04901, 
DRB1*05401, DRB1*05601, DQA1*01101, DQA1*012011, DQA1*014012, 
DQB1*03901, DQB1*04001, DQB1*04401, and DQB1*05601 (Kennedy et al. 
2007b). This means that in order to obtain a comprehensive picture of the genetic 
variation at the MHC class II loci in Scandinavian wolves more Russian wolves, 
preferably those close to Finland need to be sampled. 
According to this study the most polymorphic DLA locus was DRB1 which 
further supports the hypothesis that recombination rarely occurs between DQA1 
and DQB1. The reason for why DRB1 is more polymorphic could be that selection 
favors mutations in DRB1 rather than recombination of DQA1 and DQB1, and that 
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it is vital for the reproductive success for the latter not to recombine. The same 
conclusion was reached by Kennedy et al. (2007c).   
After comparison of MHC alleles with the MHC alleles of Ethiopian wolves 
(Kennedy et al. 2010) it could be concluded that they didn’t share any alleles. Be-
cause of this neither assumptions nor clues of how the Scandinavian wolf popula-
tion would respond to rabies vaccination could be made. 
As dogs are descendants of wolves it is not surprising that they share so many 
DLA alleles. It would not be unexpected if all alleles found in wolves will later be 
found in dogs. Neither would it be startling to discover that wolves indeed carry 
unique alleles, because not all wolves have contributed to the variation of dogs, 
and given that recombination occurs. Also, there is a possibility that recent (during 
the last few hundred years) wolf-dog hybridization is responsible for the shared 
alleles (Kennedy et al. 2007c, von Holdt et al. 2010).  
During license hunting in Sweden there is no selection of which wolves that 
are to be shot. This can potentially lead to genetically valuable animals being lost. 
Because there is a difference in how much genetic variation the wolves carry, 
there should be a better way of choosing what animals to kill, to avoid further in-
breeding. 
Another, and probably more efficient, way of measuring the genetic variation 
instead of measuring MHC class II variation, of the Scandinavian wolf population 
would be to sample the wolves and run them on a 170.000 dog SNP chip 
(CanineHD Genotyping BeadChip, Illumina). This would pick up the total varia-
tion of the wolves in a more manageable, labor and cost effective way. 
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6 Conclusion 
The wolves from the Scandinavian wolf population are not affected by any of the 
monogenic eye diseases; Gr_PRA1, Prcd-PRA, Cord1, Type-A PRA or PLL.  This 
does not mean that they do not carry any other mutation causing hereditary blind-
ness such as in captive wolves. The population has about half of the variation ex-
hibited by a common dog breed at the MHC class II loci and is in dire need of all 
the immigrating variation it can get. Because of this, license hunting should be 
abandoned in favor of careful testing of genetic variation, and depending on the 
result, cautious selection of what animals to euthanize. 
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4574 Carrier
4778 Carrier
8321 Carrier
5675 Affected
6855 Normal
7018 Normal
7020 Normal
5313 Carrier
7021 Normal
5429 Affected
5476 Affected
5479 Affected
Miniature Bull terrier
Lancshire heeler
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7 Appendix  
Table of the dog controls used for the various genetic tests. 
  
  
Gene Breed ID Genotype
ESS-003 Normal
ESS-004 Carrier
ESS-005 Normal
ESS-006 Carrier
ESS-007 Normal
ESS-008 Affected
ESS-009 Normal
ESS-010 Normal
ESS-011 Carrier
ESS-012 Normal
ESS-013 Carrier
ESS-014 Affected
ESS-015 Normal
ESS-016 Carrier
ESS-017 Normal
ESS-018 Normal
ESS-019 Normal
ESS-020 Carrier
ESS-021 Normal
GR109 Affected
GR203 Affected
GR305 Carrier
GR326 Normal
FS-01 Normal
FS-02 Normal
RP
G
G
RI
P1
SL
C4
A3
En
gl
is
h 
Sp
rin
ge
r S
pa
ni
el
Golden Retriever
Field Spaniel
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ESS-001 Normal
ESS-002 Normal
ESS-003 Normal
ESS-004 Normal
ESS-005 Normal
ESS-006 Normal
ESS-007 Normal
ESS-008 Normal
ESS-009 Normal
ESS-010 Normal
ESS-011 Normal
ESS-012 Normal
ESS-013 Normal
ESS-014 Normal
ESS-015 Normal
ESS-016 Normal
ESS-017 Normal
ESS-018 Normal
ESS-019 Normal
ESS-020 Normal
ESS-021 Normal
Bobo Normal
Båne Normal
Cindra Affected
Caspian Normal
Zingo Normal
Labrador Retriever
Pr
cd
En
gl
is
h 
Sp
rin
ge
r S
pa
ni
el
dvs01 Affected
dvs02 Affected
dvs03 Affected
dvs04 Affected
dvs05 Affected
dvs06 Affected
dvs07 Carrier
dvs08 Affected
dvs09 Carrier
dvs10 Affected
dvs11 Affected
dvs12 Affected
dvs13 Affected
dvs14 Affected
dvs15 Affected
dvs16 Affected
dvs17 Affected
dvs18 Affected
dvs19 Affected
dvs20 Affected
dvs21 Carrier
M
in
ia
tu
re
 S
ch
na
uz
er
PD
C
  
L4 
L5 
L1 
L3 
L2 
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CCR-001 Normal
CCR-002 Normal
CCR-003 Normal
CCR-004 Normal
CCR-005 Normal
CCR-006 Normal
CCR-007 Normal
CCR-008 Normal
CCR-009 Normal
CCR-010 Normal
CCR-011 Normal
CCR-012 Normal
CCR-013 Normal
CCR-014 Normal
CCR-015 Normal
CCR-016 Normal
CCR-017 Normal
CCR-018 Normal
CCR-019 Normal
CCR-020 Normal
CCR-021 Normal
CCR-022 Normal
CCR-024 Normal
CCR-025 Normal
CCR-026 Normal
CCR-027 Normal
CCR-028 Normal
CCR-029 Normal
CCR-030 Normal
CCR-031 Normal
CCR-032 Normal
CCR-033 Normal
CCR-034 Normal
CCR-035 Normal
CCR-036 Normal
CCR-037 Normal
CCR-038 Normal
CCR-039 Normal
CCR-040 Normal
CCR-041 Normal
CCR-042 Normal
CCR-043 Normal
CCR-044 Normal
CCR-045 Normal
CCR-046 Normal
CCR-047 Normal
CCR-048 Normal
CCR-049 Normal
CCR-050 Normal
CCR-051 Normal
CCR-052 Normal
CCR-053 Normal
CCR-054 Normal
Pr
cd
Ch
in
es
e 
Cr
es
te
d
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